statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Geron Announces Updated NCCN Guidelines Recommending RYTELO (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the National Comprehensive Cancer...

Futures Slide As Ugly Mag 7, European Earnings Sour Trader Mood

Futures Slide As Ugly Mag 7, European Earnings Sour Trader Mood

 Stock futures and global markets slumped, with tech dragging the indices lower, after disappointing results from Tesla and...

Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice...

Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its second quarter 2024 financial results and business highlights before the...

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 222,660 shares of Geron...

Is Geron Stock a Buy Following Its First New Drug Approval?

Is Geron Stock a Buy Following Its First New Drug Approval...

Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers

Getty Images

 Key TakeawaysThe Food and Drug Administration approved Geron's drug Rytelo for those with rare blood cancers who are suffering from anemia.Geron said Rytelo could triple the time...

FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug

FDA approves Geron's Rytelo (imetelstat) for adults with low-to intermediate-1 risk myelodysplastic syndromes and transfusion-dependent anemia Geron's first commercial treatment targets a market...

Global Rally Sputters With US Futures Flat Ahead Of Payrolls

Global Rally Sputters With US Futures Flat Ahead Of Payrolls

 The global stock rally faltered as US equity futures were unchanged for the second day in a row this morning and trading...

GameStop, DocuSign fall premarket; Lyft, Geron rise

Investing.com -- U.S. stock futures traded in a muted fashion Friday, as investors awaited the release of the highly-anticipated nonfarm payrolls release...

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Volume	12.88M
52-Wk High	$5.34
52-Wk Low	$1.64

GERN Geron Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals